<DOC>
	<DOCNO>NCT02760732</DOCNO>
	<brief_summary>This study investigate effect safety drug elute balloon combine treatment unstable angina .</brief_summary>
	<brief_title>Drug Eluting Balloon Treatment Unstable Angina</brief_title>
	<detailed_description>Patients unstable angina randomize drug elute stent drug elute balloon group . Angiographic follow-up perform 12 month . The primary endpoint late lumen loss ( LLL ) secondary endpoint target lesion revascularization ( TLR ) , major adverse cardiovascular event ( MACE ) .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<criteria>Patients &gt; 18 , &lt; 80 year old , unstable angina Singlevessel doublevessel disease Length target lesion &lt; 25mm Diameter target vessel &gt; 2.5mm , &lt; 3.5mm Left main disease Chronic total occlusion Severe Tortuosity Heavy calcification Severe liver failure , moderate severe kidney failure Malignant disease Active infectious disease Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>